share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：拟议出售证券
美股sec公告 ·  07/11 10:43
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer and director, Gibson Christopher, is set to sell 50,000 Class A shares on 07/11/2024, as per the latest SEC filing. The shares, valued at an aggregate market price of $373,500, were originally acquired on 09/01/2016 as founder's shares in compensation for services rendered. This planned sale follows a series of transactions over the past three months where a total of 250,000 shares were sold for gross proceeds of $2,055,000. The upcoming sale is in line with a trading plan adopted on 12/27/2023.
Recursion Pharmaceuticals, Inc. officer and director, Gibson Christopher, is set to sell 50,000 Class A shares on 07/11/2024, as per the latest SEC filing. The shares, valued at an aggregate market price of $373,500, were originally acquired on 09/01/2016 as founder's shares in compensation for services rendered. This planned sale follows a series of transactions over the past three months where a total of 250,000 shares were sold for gross proceeds of $2,055,000. The upcoming sale is in line with a trading plan adopted on 12/27/2023.
Recursion Pharmaceuticals, Inc. 的官员和董事 Gibson Christopher 打算在 2024 年 07 月 11 日卖出 50,000 股 A 类股票，根据最新的 SEC 报告。这些股票的总市场价格为 373,500 美元，最初于 2016 年 09 月 01 日以创始人股份的形式获得，作为提供服务的报酬。在过去三个月中，已完成了一系列交易，总共卖出 250,000 股股份，总毛收入为 2,055,000 美元。即将进行的出售符合于 2023 年 12 月 27 日采用的交易计划。
Recursion Pharmaceuticals, Inc. 的官员和董事 Gibson Christopher 打算在 2024 年 07 月 11 日卖出 50,000 股 A 类股票，根据最新的 SEC 报告。这些股票的总市场价格为 373,500 美元，最初于 2016 年 09 月 01 日以创始人股份的形式获得，作为提供服务的报酬。在过去三个月中，已完成了一系列交易，总共卖出 250,000 股股份，总毛收入为 2,055,000 美元。即将进行的出售符合于 2023 年 12 月 27 日采用的交易计划。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息